We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.5B
AUM Growth
+$748M
Cap. Flow
+$681M
Cap. Flow %
45.46%
Top 10 Hldgs %
71.8%
Holding
659
New
195
Increased
97
Reduced
113
Closed
226

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$21.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$17M
3
AVGO icon
Broadcom
AVGO
+$16.6M
4
MRVL icon
Marvell Technology
MRVL
+$14.3M
5
TMUS icon
T-Mobile US
TMUS
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.98%
2 Technology 3.97%
3 Financials 3.94%
4 Consumer Discretionary 2.88%
5 Industrials 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBF icon
201
PBF Energy
PBF
$7.77B
$611K 0.04%
14,972
-19,893
-57% -$827K
CHD icon
202
Church & Dwight Co
CHD
$24.5B
$604K 0.04%
7,499
-6,211
-45% -$477K
ALRM icon
203
Alarm.com
ALRM
$2.8B
$600K 0.04%
+12,134
New +$669K
LNC icon
204
Lincoln National
LNC
$8.79B
$599K 0.04%
19,498
+11,005
+130% +$437K
NMFC icon
205
New Mountain Finance
NMFC
$725M
$598K 0.04%
+48,360
New +$596K
NATI
206
DELISTED
National Instruments Corp
NATI
$597K 0.04%
+16,171
New +$632K
PSEC icon
207
Prospect Capital
PSEC
$1.14B
$592K 0.04%
+84,709
New +$609K
NKTR icon
208
Nektar Therapeutics
NKTR
$2.54B
$587K 0.04%
17,312
+13,943
+414% +$675K
GD icon
209
General Dynamics
GD
$107B
$586K 0.04%
+2,361
New +$576K
ACMR icon
210
ACM Research
ACMR
$5.67B
$585K 0.04%
+75,895
New +$643K
NBIX icon
211
Neurocrine Biosciences
NBIX
$16.7B
$582K 0.04%
4,869
+1,874
+63% +$219K
CHRW icon
212
C.H. Robinson
CHRW
$17.4B
$579K 0.04%
+6,329
New +$603K
AWI icon
213
Armstrong World Industries
AWI
$7.74B
$578K 0.04%
+8,427
New +$637K
TK icon
214
Teekay
TK
$978M
$578K 0.04%
+127,211
New +$529K
RYAM icon
215
Rayonier Advanced Materials
RYAM
$599M
$572K 0.04%
59,569
+9,869
+20% +$62.8K
KNDI
216
Kandi Technologies Group
KNDI
$63.8M
$567K 0.04%
246,643
-17,422
-7% -$45.7K
CBRL icon
217
Cracker Barrel
CBRL
$1.25B
$566K 0.04%
+5,969
New +$622K
DOV icon
218
Dover
DOV
$28.4B
$565K 0.04%
4,171
-228
-5% -$30.3K
LHCG
219
DELISTED
LHC Group LLC
LHCG
$563K 0.04%
+3,483
New +$575K
RHI icon
220
Robert Half
RHI
$4.32B
$554K 0.04%
7,497
-5,918
-44% -$451K
HNRG icon
221
Hallador Energy
HNRG
$731M
$553K 0.04%
55,375
+32,574
+143% +$268K
NDSN icon
222
Nordson
NDSN
$17.3B
$551K 0.04%
+2,319
New +$530K
RNR icon
223
RenaissanceRe
RNR
$13.4B
$541K 0.04%
+2,934
New +$494K
PTEN icon
224
Patterson-UTI
PTEN
$4.13B
$540K 0.04%
+32,040
New +$529K
BF.B icon
225
Brown-Forman Class B
BF.B
$12.9B
$534K 0.04%
8,127
+5,078
+167% +$345K

Similar funds

Caxton Associates (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.

  • Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
  • Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
  • Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
  • Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
  • Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
  • Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.